Heparin-binding epidermal growth factor-like growth factor gene disruption is associated with delayed intestinal restitution, impaired angiogenesis, and poor survival after intestinal ischemia in mice

Journal of Pediatric Surgery

Volumn 43, Issue 6, 2008, Pages 1182-1190

  El Assal, Osama N ^a   Paddock, Heather ^a   Marquez, Alejandro ^a   Besner, Gail E ^a  

^a THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

Angiogenesis; Heparin binding epidermal growth factor like growth factor; Intestine; Ischemia reperfusion injury

Indexed keywords

HEPARIN BINDING EPIDERMAL GROWTH FACTOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GENE DELETION; GENE DISRUPTION; HISTOLOGY; IMMUNOHISTOCHEMISTRY; INTESTINE ISCHEMIA; INTESTINE MUCOSA PERMEABILITY; KAPLAN MEIER METHOD; MALE; MICROVASCULATURE; MORTALITY; MOUSE; NECROTIZING ENTEROCOLITIS; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; STATISTICAL SIGNIFICANCE; SUPERIOR MESENTERIC ARTERY OBSTRUCTION; SURVIVAL; WILD TYPE; WOUND HEALING;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTESTINES; ISCHEMIA; KAPLAN-MEIERS ESTIMATE; MALE; MICE; MICE, INBRED STRAINS; NEOVASCULARIZATION, PATHOLOGIC; RANDOM ALLOCATION; REFERENCE VALUES; REPERFUSION INJURY; SURVIVAL RATE;

EID: 44949244211     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpedsurg.2008.02.053     Document Type: Article

References (33)

1. Marik P.E. Total splanchnic resuscitation, SIRS, and MODS. Crit Care Med 27 (1999) 257-258
2. Chiara O., Pelosi P., Segala M., et al. Mesenteric and renal oxygen transport during hemorrhage and reperfusion: evaluation of optimal goals for resuscitation. J Trauma 51 (2001) 356-362
3. Besner G., Higashiyama S., and Klagsbrun M. Isolation and characterization of a macrophage-derived heparin-binding growth factor. Cell Regul 1 (1990) 811-819
4. Higashiyama S., Abraham J.A., Miller J., et al. A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science 251 (1991) 936-939
5. El-Assal O.N., and Besner G.E. HB-EGF enhances restitution after intestinal ischemia/reperfusion via PI3K/Akt and MEK/ERK1/2 activation. Gastroenterology 129 (2005) 609-625
6. El-Assal O.N., Radulescu A., and Besner G.E. Heparin-binding EGF-like growth factor preserves mesenteric microcirculatory blood flow and protects against intestinal injury in rats subjected to hemorrhagic shock and resuscitation. Surgery 142 (2007) 234-242
7. Podolsky D.K. Mucosal immunity and inflammation. V. Innate mechanisms of mucosal defense and repair: the best offense is a good defense. Am J Physiol 277 (1999) G495-G499
8. Cribbs R.K., Harding P.A., Luquette M.H., et al. Endogenous production of heparin-binding EGF-like growth factor during murine partial-thickness burn wound healing. J Burn Care Rehabil 23 (2002) 116-125
9. Jin K., Mao X.O., Sun Y., et al. Heparin-binding epidermal growth factor-like growth factor: hypoxia-inducible expression in vitro and stimulation of neurogenesis in vitro and in vivo. J Neurosci 22 (2002) 5365-5373
10. Frank G.D., Mifune M., Inagami T., et al. Distinct mechanisms of receptor and nonreceptor tyrosine kinase activation by reactive oxygen species in vascular smooth muscle cells: role of metalloprotease and protein kinase C-delta. Mol Cell Biol 23 (2003) 1581-1589
11. Ellis P.D., Hadfield K.M., Pascall J.C., et al. Heparin-binding epidermal-growth-factor-like growth factor gene expression is induced by scrape-wounding epithelial cell monolayers: involvement of mitogen-activated protein kinase cascades. Biochem J 354 (2001) 99-106
12. Sakai M., Zhang M., Homma T., et al. Production of heparin binding epidermal growth factor-like growth factor in the early phase of regeneration after acute renal injury. Isolation and localization of bioactive molecules. J Clin Invest 99 (1997) 2128-2138
13. Tanaka N., Masamura K., Yoshida M., et al. A role of heparin-binding epidermal growth factor-like growth factor in cardiac remodeling after myocardial infarction. Biochem Biophys Res Commun 297 (2002) 375-381
14. Faull R.J., Stanley J.M., Fraser S., et al. HB-EGF is produced in the peritoneal cavity and enhances mesothelial cell adhesion and migration. Kidney Int 59 (2001) 614-624
15. Tokumaru S., Higashiyama S., Endo T., et al. Ectodomain shedding of epidermal growth factor receptor ligands is required for keratinocyte migration in cutaneous wound healing. J Cell Biol 151 (2000) 209-220
16. Abramovitch R., Neeman M., Reich R., et al. Intercellular communication between vascular smooth muscle and endothelial cells mediated by heparin-binding epidermal growth factor-like growth factor and vascular endothelial growth factor. FEBS Lett 425 (1998) 441-447
17. Ongusaha P.P., Kwak J.C., Zwible A.J., et al. HB-EGF is a potent inducer of tumor growth and angiogenesis. Cancer Res 64 (2004) 5283-5290
18. Zhang L., Koivisto L., Heino J., et al. Bacterial heat shock protein 60 may increase epithelial cell migration through activation of MAP kinases and inhibition of alpha6beta4 integrin expression. Biochem Biophys Res Commun 319 (2004) 1088-1095
19. Iivanainen E., Nelimarkka L., Elenius V., et al. Angiopoietin-regulated recruitment of vascular smooth muscle cells by endothelial-derived heparin binding EGF-like growth factor. FASEB J 17 (2003) 1609-1621
20. Jackson L.F., Qiu T.H., Sunnarborg S.W., et al. Defective valvulogenesis in HB-EGF and TACE-null mice is associated with aberrant BMP signaling. EMBO J 22 (2003) 2704-2716
21. Chiu C.J., McArdle A.H., Brown R., et al. Intestinal mucosal lesion in low-flow states. Arch Surg 101 (1970) 478-483
22. El-Assal O.N., Yamanoi A., Soda Y., et al. Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver. Hepatology 27 (1998) 1554-1562
23. Brandt L.J., and Boley S.J. AGA technical review on intestinal ischemia. American Gastrointestinal Association. Gastroenterology 118 (2000) 954-968
24. Pillai S.B., Hinman C.E., Luquette M.H., et al. Heparin-binding epidermal growth factor-like growth factor protects rat intestine from ischemia/reperfusion injury. J Surg Res 87 (1999) 225-231
25. Brasken P., Lehto M., and Renvall S. Changes in the connective tissue composition of the submucosal layer of colonic anastomosis. An immunohistologic study in rats. Acta Chir Scand 155 (1989) 413-419
26. Wise L., McAlister W., Stein T., et al. Studies on the healing of anastomoses of small and large intestines. Surg Gynecol Obstet 141 (1975) 190-194
27. Kume N., and Gimbrone Jr. M.A. Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells. J Clin Invest 93 (1994) 907-911
28. Mehta V., and Besner G. HB-EGF promotes angiogenesis in endothelial cells via PI3-kinase and MAPK signaling pathways. Growth Factors 25 (2007) 253-263
29. Zakaria el R., Garrison R.N., Kawabe T., et al. Role of neutrophils on shock/resuscitation-mediated intestinal arteriolar derangements. Shock 21 (2004) 248-253
30. Horie Y., Wolf R., Anderson D.C., et al. Hepatic leukostasis and hypoxic stress in adhesion molecule-deficient mice after gut ischemia/reperfusion. J Clin Invest 99 (1997) 781-788
31. Rocourt D.V., Mehta V.B., Wu D., et al. Heparin-binding EGF-like growth factor decreases neutrophil-endothelial cell interactions. J Surg Res 141 (2007) 262-266
32. Xia G., Martin A.E., and Besner G.E. Heparin-binding EGF-like growth factor downregulates expression of adhesion molecules and infiltration of inflammatory cells after intestinal ischemia/reperfusion injury. J Pediatr Surg 38 (2003) 434-439
33. Chalothorn D., Moore S.M., Zhang H., et al. Heparin-binding epidermal growth factor-like growth factor, collateral vessel development, and angiogenesis in skeletal muscle ischemia. Arterioscler Thromb Vasc Biol 25 (2005) 1884-1890